GB0224232D0 - Use of fluoroquinolone antibodies for the treatment of anthrax - Google Patents

Use of fluoroquinolone antibodies for the treatment of anthrax

Info

Publication number
GB0224232D0
GB0224232D0 GBGB0224232.9A GB0224232A GB0224232D0 GB 0224232 D0 GB0224232 D0 GB 0224232D0 GB 0224232 A GB0224232 A GB 0224232A GB 0224232 D0 GB0224232 D0 GB 0224232D0
Authority
GB
United Kingdom
Prior art keywords
fluoroquinolone
anthrax
antibodies
treatment
fluoroquinolone antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0224232.9A
Other versions
GB2394177A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Priority to GB0224232A priority Critical patent/GB2394177A/en
Publication of GB0224232D0 publication Critical patent/GB0224232D0/en
Publication of GB2394177A publication Critical patent/GB2394177A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0224232A 2002-10-18 2002-10-18 Use of fluoroquinolone antibiotics for the treatment of anthrax Withdrawn GB2394177A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0224232A GB2394177A (en) 2002-10-18 2002-10-18 Use of fluoroquinolone antibiotics for the treatment of anthrax

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0224232A GB2394177A (en) 2002-10-18 2002-10-18 Use of fluoroquinolone antibiotics for the treatment of anthrax

Publications (2)

Publication Number Publication Date
GB0224232D0 true GB0224232D0 (en) 2002-11-27
GB2394177A GB2394177A (en) 2004-04-21

Family

ID=9946123

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0224232A Withdrawn GB2394177A (en) 2002-10-18 2002-10-18 Use of fluoroquinolone antibiotics for the treatment of anthrax

Country Status (1)

Country Link
GB (1) GB2394177A (en)

Also Published As

Publication number Publication date
GB2394177A (en) 2004-04-21

Similar Documents

Publication Publication Date Title
HUS2200036I1 (en) Use of dihydroimidazolones for the treatment of dogs
GB0312832D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
IL173386A0 (en) Use of adcc-optimized antibodies for treating weak patients
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
EP1750513A4 (en) Use of gpcr54 ligands for the treatment of infertility
IL178827A0 (en) Use of reboxetine for the treatment of pain
GB0329874D0 (en) Compounds useful for the treatment of diseases
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AP2005003336A0 (en) Combination for the treatment of ADHD
PT1487828E (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AU2003290059A8 (en) Use of cd137 antagonists for the treatment of tumors
PL377464A1 (en) Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
IL175412A0 (en) Use of specific histones for the treatment of parasitic diseases
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
IL161748A0 (en) New use for the treatment of gastroesophageal reflux
GB0415181D0 (en) Compounds for use in the treatment of infection
GB0224232D0 (en) Use of fluoroquinolone antibodies for the treatment of anthrax
ZA200606780B (en) Compounds for the treatment of diseases
IL175611A0 (en) Combinations for the treatment of proliferative diseases
GB0307262D0 (en) Use of fluoroquinolone antibiotics for the treatment of q fever
GB0316139D0 (en) Use of fluoroquinolone antibiotics for the treatment of plague
AU2003245995A8 (en) Use of gaba-c receptor antagonists for the treatment of myopia

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)